U.S. Beverage Stock News

NYSE:NVRI
NYSE:NVRICommercial Services

Should Widening Losses Amid Stable Sales Require Action From Enviri (NVRI) Investors?

Enviri Corporation recently reported its fourth-quarter and full-year 2025 results, with full-year revenue of US$2,240.36 million versus US$2,343.14 million a year earlier and a wider net loss of US$167.60 million compared with US$129.65 million. The persistence of losses and higher loss per share, despite relatively steady revenue, highlights pressure on profitability and the company’s ongoing financial strain. With these earnings showing revenue slippage and a larger annual loss, we’ll now...
NYSE:OI
NYSE:OIPackaging

Why O-I Glass (OI) Is Down 13.6% After Tougher Q1 2026 Europe And Pricing Pressure

O-I Glass recently reported that the first quarter of 2026 was tougher than expected, citing softer European demand, supply chain costs from factory closures, and pricing pressure in wine, even as it kept its full-year outlook unchanged. At the same time, the company nearly doubled adjusted earnings to US$1.60 per share in 2025, lifted by US$300 million of Fit to Win savings, and raised its three-year efficiency target to at least US$750 million, underscoring management’s focus on...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

A Look At AbCellera Biologics (ABCL) Valuation After Annual Earnings Reveal Higher Revenue And A Narrower Net Loss

AbCellera Biologics (ABCL) is back in focus after releasing full year 2025 results, reporting revenue of US$75.13 million compared with US$28.83 million a year earlier and a net loss of US$146.41 million compared with US$162.86 million. See our latest analysis for AbCellera Biologics. AbCellera Biologics’ latest earnings drop comes after a mixed period for investors, with a 1-month share price return of 11.39% but a 3-year total shareholder return decline of 52.56% and a 5-year total...
NYSE:CR
NYSE:CRMachinery

Crane (CR) Valuation Check After Q4 2025 Earnings Reignite Growth And Lift Analyst Expectations

Q4 2025 earnings shift focus back to Crane’s top line Crane (CR) is back in the spotlight after reporting higher sales and earnings for Q4 and full year 2025, ending a multi year revenue decline and prompting analysts to revisit their growth assumptions. See our latest analysis for Crane. Crane’s recent Q4 update lands after a strong run for long term holders, with a 1 year total shareholder return of 26.62% and a 5 year total shareholder return of 231.46%. At the same time, the 7 day share...
NasdaqCM:LTRX
NasdaqCM:LTRXCommunications

MediaTek Edge AI Expansion and EU Deal Could Be A Game Changer For Lantronix (LTRX)

In early March 2026, Lantronix Inc. expanded its embedded compute platform with new MediaTek Genio-based System-on-Module solutions and signed a European distribution partnership with Milan-based Melchioni Electronics to broaden sales and technical support across key EU markets. Together, the MediaTek-powered Edge AI modules and Melchioni’s regional reach materially widen Lantronix’s addressable markets, design-win potential and supply resilience across industrial and commercial IoT...
NasdaqGM:WLDN
NasdaqGM:WLDNProfessional Services

Can Willdan Group's (WLDN) New PSE Software Wins Redefine Its Energy Infrastructure Strategy?

In early March 2026, Willdan Group, Inc. announced it had been chosen by Puget Sound Energy to implement telecommunications and multifamily new construction programs, expand non-lighting technologies for a commercial program, and deliver software services supporting compliance with Washington State’s Clean Buildings Performance Standard. These wins, alongside a US$49 million distributed energy resources contract with Mt. San Antonio College and strong 2025 financial results, highlight...
NYSE:AZZ
NYSE:AZZBuilding

Is AZZ (AZZ) Quietly Recasting Its Board to Sharpen Capital Allocation Discipline?

AZZ Inc. recently reshaped its governance, appointing Myers Industries CEO Aaron Schapper and Vistance Networks CEO Charles “Chuck” Treadway to its Board effective April 8, 2026, while long-time chair Dan Feehan stepped down in March and was succeeded by director Dan Berce, with Feehan remaining on the Board until July 2026. These board changes, alongside an expanded stock repurchase authorization and ongoing leadership refresh, highlight AZZ’s focus on strengthening oversight, capital...
NasdaqGM:SEPN
NasdaqGM:SEPNPharmaceuticals

Assessing Septerna (SEPN) Valuation After Earnings Progress And Positive SEP-631 Phase 1 Results

Earnings and clinical progress set the stage for Septerna (SEPN) Septerna (SEPN) has drawn fresh attention after reporting fourth quarter and full year 2025 results alongside positive Phase 1 data for SEP-631 in chronic urticaria, a combination that puts both finances and pipeline in focus. See our latest analysis for Septerna. The recent earnings update and SEP-631 Phase 1 readout come after a strong run, with a 1 year total shareholder return of around 4x and a 30 day share price return of...
NYSE:QXO
NYSE:QXOTrade Distributors

QXO Highlights Women In Roofing As It Builds Contractor Relationships

QXO (NYSE:QXO) has launched its sixth annual North American Female Roofing Professional of the Year campaign. The initiative recognizes women across the roofing industry and reflects QXO’s focus on workforce inclusivity. The campaign invites nominations of standout female professionals, offering company backed recognition and support. For you as an investor, this campaign speaks to how QXO is positioning itself within the roofing supply and services ecosystem, not just as a distributor or...
NasdaqGS:EFSC
NasdaqGS:EFSCBanks

Assessing Enterprise Financial Services (EFSC) Valuation After Recent Short Term Share Price Weakness

Event context and recent share performance Enterprise Financial Services (EFSC) has drawn investor attention after recent trading, with the stock down about 1% over the past day, 6% over the past week, and roughly 10% over the past month. Those shorter term moves contrast with a small positive total return over the past year, as well as higher three and five year total returns. This has prompted some investors to reassess how the bank’s current pricing lines up with its fundamentals. See our...
NasdaqGS:ERII
NasdaqGS:ERIIMachinery

A Look At Energy Recovery (ERII) Valuation After PX Q650 Desalination Launch

Why the PX Q650 launch matters for Energy Recovery (ERII) investors Energy Recovery (ERII) has drawn fresh attention after launching its PX Q650 Pressure Exchanger for desalination, combining higher flow capacity, very high stated efficiency, and extended warranties aimed at long-life plant operations. See our latest analysis for Energy Recovery. The PX Q650 launch comes on the heels of Energy Recovery’s recent earnings update. It arrives at a time when the stock has seen a 4.81% 1 day share...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

Is New HIV Switch Data Reframing the Investment Case for Gilead Sciences’ Lenacapavir Platform (GILD)?

In February 2026, Gilead Sciences presented Phase 3 ARTISTRY-1 and ARTISTRY-2 data showing its investigational single-tablet bictegravir/lenacapavir HIV regimen maintained virologic suppression and was generally well tolerated, proving noninferior to both complex multi-tablet regimens and guideline-recommended single-tablet therapy through Week 48. This potential new once-daily option could simplify treatment for people living with HIV who are currently on complex regimens, reinforcing...
NasdaqGM:IESC
NasdaqGM:IESCConstruction

Does IES Holdings (IESC) Director Share Sale Recast the Story on Governance and Capital Allocation?

IES Holdings recently held its 2026 Annual Stockholders Meeting, where all director nominees were elected and Ernst & Young was ratified as auditor, while Director Todd Cleveland sold 2,500 shares, trimming his personal stake. Together with ongoing attention on the Gulf Island acquisition, these governance developments are sharpening investor focus on how IES allocates capital and manages oversight. Next, we’ll examine how the director’s share sale and refreshed governance framework shape...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Profit Swing, MIPLYFFA Uptake and New CFO Might Change The Case For Investing In Zevra Therapeutics (ZVRA)

Zevra Therapeutics, Inc. has reported its 2025 results, with full-year sales rising to US$106.47 million and net income reaching US$83.23 million, alongside fourth-quarter revenue of US$34.1 million and adjusted earnings of US$1.16 per share. Alongside these results, Zevra filed a US$22.86 million employee stock offering and named veteran finance executive Justin Renz as its new Chief Financial Officer, underscoring a focus on commercial scale-up and corporate development. We’ll now examine...
NYSE:COR
NYSE:CORHealthcare

How Earnings Beat, Higher Guidance And Dividend Hike At Cencora (COR) Has Changed Its Investment Story

Cencora recently reported fiscal first-quarter 2026 adjusted earnings per share of US$4.08, slightly above estimates and 9.4% higher year over year, and raised its full-year guidance for revenue and adjusted operating income while declaring a US$0.60 quarterly dividend. Shareholders reinforced board continuity and executive direction at the 2026 Annual Meeting, as Cencora continues expanding in specialty distribution and European markets while addressing higher expenses and an impairment in...
NYSE:REZI
NYSE:REZIBuilding

Why Resideo Technologies (REZI) Is Down 7.5% After Mixed 2025 Results And Cautious 2026 Outlook – And What's Next

Resideo Technologies reported past fourth-quarter 2025 results with sales of US$1,895 million and net income of US$136 million, alongside full-year 2025 sales of US$7.47 billion but a net loss of US$527 million. The company also issued 2026 guidance calling for net revenue of US$1,866 million to US$1,890 million in the first quarter and US$7.80 billion to US$7.90 billion for the full year, highlighting a contrast between recent quarterly profitability and a loss-making full year. Against...
NYSE:RBA
NYSE:RBACommercial Services

RB Global (RBA) Is Up 5.7% After Authorizing US$500M Buyback Program Has The Bull Case Changed?

RB Global, Inc. recently announced that its Board of Directors has authorized a share repurchase program of up to US$500,000,000, subject to Toronto Stock Exchange approval and funded through cash reserves or its senior credit facility. This sizable buyback authorization, coming alongside strong quarterly results that exceeded analyst expectations, highlights management’s confidence in deploying capital to support shareholder value. We’ll now examine how the newly authorized US$500,000,000...
NasdaqGS:CATY
NasdaqGS:CATYBanks

Assessing Cathay General Bancorp (CATY) Valuation After Recent Share Price Weakness

Cathay General Bancorp (CATY) has drawn investor attention after a recent share price decline, including a 12% drop over the past month, even as the bank reports US$745.261m in revenue and US$315.124m in net income. See our latest analysis for Cathay General Bancorp. That recent 12% monthly share price pullback fits into a softer short term trend, with a 30 day share price return of an 11.79% decline and a 90 day return of a 3.15% decline, even though the 1 year total shareholder return of...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

Is Neogen (NEOG) Pricing Make Sense After Mixed Share Performance This Year

If you are trying to figure out whether Neogen's current share price makes sense, you are not alone. A closer look at its valuation tools can help you frame that question more clearly. Neogen recently closed at US$9.70, with returns of a 13% decline over 7 days, a 10.2% decline over 30 days, a 38.6% gain year to date, and a 2.8% decline over the last year. This combination gives a mixed picture of how the market is currently pricing the stock. Recent coverage around Neogen has focused on the...
NasdaqGS:PLPC
NasdaqGS:PLPCElectrical

Why Preformed Line Products' (PLPC) Rising Sales With Softer EPS May Recast Its Margin Narrative

Preformed Line Products Company previously reported fourth-quarter 2025 results, with sales rising to US$173.11 million while net income eased to US$8.44 million, and full-year 2025 sales increasing to US$669.34 million alongside slightly lower earnings per share. The combination of higher revenue with reduced profitability suggests rising costs or margin pressure, raising questions about the quality and sustainability of recent growth. We’ll now examine how rising full-year sales alongside...
NasdaqGS:ALLT
NasdaqGS:ALLTSoftware

How Investors May Respond To Allot (ALLT) Returning To Profitability With 2026 Revenue Growth Guidance

In February 2026, Allot Ltd. reported fourth-quarter 2025 sales of US$28.39 million and net income of US$2.9 million, alongside full-year 2025 sales of US$101.99 million and net income of US$3.71 million, marking a shift from a loss a year earlier. At the same time, the company guided for 2026 revenue of US$113 million to US$117 million, signaling management’s confidence in accelerating growth after its return to profitability. Next, we’ll examine how Allot’s return to profitability and...
NasdaqGS:LLYV.K
NasdaqGS:LLYV.KConsumer Services

Is Liberty Live (LLYV.K) Rotating Legal Leadership to Quietly Reposition Its Deal‑Making Strategy?

Liberty Media Corporation recently announced that Renee Wilm will move from her role as Chief Legal Officer and Chief Administrative Officer of Liberty Media, Liberty Live and Liberty Broadband to become Senior Advisor later in 2026, while continuing as Chief Legal Officer at GCI Liberty, Inc. This shift marks a change in legal and transactional leadership after more than two decades of Ms. Wilm’s involvement in major deals and restructurings across the Liberty group. Next, we’ll assess how...
NasdaqGS:KYIV
NasdaqGS:KYIVWireless Telecom

Kyivstar Group (NasdaqGS:KYIV) Valuation Check As Recent Weak Trading Contrasts With DCF Upside Estimate

Why Kyivstar Group is on investors’ radar today Kyivstar Group (KYIV) has caught investor attention after recent trading left the shares around $11.77, with performance over the past month and past 3 months both in negative territory. See our latest analysis for Kyivstar Group. Recent trading has been weak, with a 1-day share price return showing a 0.93% decline and a 90-day share price return showing a 17.58% decline. However, the 1-year total shareholder return of 1.99% indicates that...
NasdaqGS:INSG
NasdaqGS:INSGCommunications

Is Inseego's (INSG) Unified 5G Edge Strategy Deepening Its Moat or Stretching It Too Thin?

Inseego recently introduced the MiFi PRO M4 enterprise mobile router, built on its new ConnectOS software and Qualcomm’s Dragonwing MBB Gen 3 platform, while also unveiling an enhanced Inseego Subscribe SaaS BSS solution for complex enterprise and government subscriber lifecycle management. Together, these launches highlight Inseego’s push to create a unified wireless edge architecture that blends 5G hardware, cloud management, and enterprise-grade security into an integrated offering for...